胆道恶性肿瘤全程规范化管理中国专家共识(2023)

Chinese expert consensus on the whole-course standardized management of biliary tract cancer(2023)

胆道恶性肿瘤早期诊断困难,多数患者首诊时已处于进展期,肿瘤根治性切除率低、综合治疗手段有限、患者预后差。目前我国胆道系统疾病专科诊疗及多学科协作机制构建尚不完善,而胆道恶性肿瘤的诊疗模式日趋复杂。为了更好地对胆道恶性肿瘤患者进行规范化诊治,切实提升全国各级医疗机构对胆道恶性肿瘤的全程化管理能力,中华医学会外科学分会胆道外科学组、中国医师协会外科医师分会胆道外科专家工作组基于现有循证医学证据,组织相关领域专家充分讨论后制定了《胆道恶性肿瘤全程规范化管理中国专家共识(2023)》,共识内容涵盖了胆道恶性肿瘤的筛查、诊断、治疗及随访等环节,希望为胆道恶性肿瘤患者的规范化全程化管理提供指导性建议。

The early detection of biliary tract cancer remains challenging,with the majority of patients often presenting at an advanced stage,characterized by a low rate of radical surgery,limited comprehensive treatment options,and poor prognosis.Currently,the specialized diagnosis and treatment of biliary system diseases,as well as the establishment of multi-disciplinary collaboration strategy,are still developing in China.Given the increasing complexity of biliary tract cancer diagnosis and treatment,the Study Group of Biliary Surgery in Chinese Society of Surgery of Chinese Medical Association and the Biliary Surgeon Working Group of the Surgical Branch of the Chinese Medical Doctor Association have developed this"Chinese expert consensus on the whole-course standardized management of biliary tract cancer(2023)".This consensus has been based on current medical evidence and was reached through expert discussions.It comprehensively covers screening,diagnosis,treatment,and follow-up,providing clinicians with guidance on standardized and holistic management of biliary tract cancer.